Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials

Therapeutics and Clinical Risk Management

Volumn 4, Issue 5, 2008, Pages 1097-1103

  Taku, Kyoko ^a   Umegaki, Keizo ^a   Ishimi, Yoshiko ^a   Watanabe, Shaw ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Extracted soy isoflavones; LDL cholesterol; Lipid; Total cholesterol

Indexed keywords

AGLYCONE; DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ARTICLE; BLOATING; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET RESTRICTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE MODIFICATION; MENOPAUSE; MENSTRUAL IRREGULARITY; META ANALYSIS; PARESTHESIA; PROTEIN CONTENT; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SOYBEAN; STOMACH PAIN; SYSTEMATIC REVIEW;

EID: 56749117731     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Badeau R, Jauhiainen M, Metso J, et al. 2007. Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women. Menopause, 14:293-9.
2. Balk E, Chung M, Chew P, et al. 2005. Effects of soy on health outcomes: Evidence report/Technology assessment No. 126. Rockville, MD: Agency for Healthcare Research and Quality.
3. Cassidy A, Albertazzi P, Lise Nielsen I, et al. 2006. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc, 65:76-92.
4. Cheng G, Wilczek B, Warner M, et al. 2007. Isoflavone treatment for acute menopausal symptoms. Menopause, 14:468-73.
5. Clarkson TB, Anthony MS. 1998. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab, 12:589-604.
6. Clarkson TB. 2002. Soy, soy phytoestrogens and cardiovascular disease. J Nutr, 132:566S-9S.
7. Cochrane Collaboration. 2006. Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.6. Accessed on March 10, 2008. URL: http://www.cochrane.org/resources/handbook/Handbook4.2.6Sep2006.pdf.
8. de Pascual-Teresa S, Hallund J, Talbot D, et al. 2006. Absorption of isoflavones in humans: effects of food matrix and processing. J Nutr Biochem, 17:257-64.
9. Dewell A, Hollenbeck CB, Bruce B. 2002. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab, 87:118-21.
10. Garrido A, De la Maza MP, Hirsch S, et al. 2006. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas, 54:270-6.
11. Gonzalez S, Jayagopal V, Kilpatrick ES, et al. 2007. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care, 30:1871-3.
12. Hall WL, Vafeiadou K, Hallund J, et al. 2006. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr, 83:592-600.
13. Jadad AR, Moore RA, Carroll D, et al. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 17:1-12.
14. Khan KS, Daya S, Jadad A. 1996. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med, 156:661-6.
15. Kokubo Y, Iso H, Ishihara J, et al. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation, 116:2553-62.
16. Linde K, Jonas WB, Melchart D, et al. 2001. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol, 30:526-31.
17. Lissin LW, Oka R, Lakshmi S, et al. 2004. Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med, 9:26-30.
18. [LMC] Laboratory Methods Committee of the Lipid Research Clinics Program of the National Heart, Lung, and Blood Institute. 1977. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem, 23:60-3.
19. Nelson HD, Vesco KK, Haney E, et al. 2006. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA, 295:2057-71.
20. Nestel PJ, Yamashita T, Sasahara T, et al. 1997. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol, 17:3392-8.
21. Nikander E, Tiitinen A, Laitinen K, et al. 2004. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab, 89:3567-72.
22. Petri Nahas E, Nahas Neto J, De Luca L, et al. 2004. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas, 48:372-80.
23. Sacks FM, Lichtenstein A, Van Horn L, et al. 2006. Soyprotein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, 113:1034-44.
24. Schulz KF, Chalmers I, Hayes RJ, et al. 1995. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 273:408-12.
25. Setchell KD, Brown NM, Zimmer-Nechemias L, et al. 2002. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr, 76:447-53.
26. Simons LA, von Konigsmark M, Simons J, et al. 2000. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol, 85:1297-301.
27. Sjogren P, Halling A. 2002. Quality of reporting randomised clinical trials in dental and medical research. Br Dent J, 192:100-3.
28. Taku K, Umegaki K, Sato Y, et al. 2007. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr, 85:1148-56.
29. Tormala RM, Nikander E, Tiitinen A, et al. 2006. Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones. Menopause, 13:96-101.
30. Uesugi S, Watanabe S, Ishiwata N, et al. 2004. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors, 22:221-8.
31. Uesugi T, Fukui Y, Yamori Y. 2002. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study. J Am Coll Nutr, 21:97-102.
32. Uesugi T, Toda T, Okuhira T, et al. 2003. Evidence of estrogenic effect by the three-month-intervention of isoflavone on vaginal maturation and bone metabolism in early postmenopausal women. Endocr J, 50:613-19.
33. Yeung J, Yu TF. 2003. Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J, 2:15.
34. Yildiz MF, Kumru S, Godekmerdan A, et al. 2005. Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet, 90:128-33.
35. Zhan S, Ho SC. 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr, 81:397-408.